stockrowBausch + Lomb Corporation
BLCO Healthcare Medical Instruments & Supplies
Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.
- Revenue
- +7.34%
- EPS
- +222.4%
- Free cash flow
- +182.5%
- Total debt
- +2.93%
Quarter to September 2026, against a year earlier
Follow BLCO
Alert me
Bausch + Lomb Corporation (BLCO) Operating cash flow
Bausch + Lomb Corporation's operating cash flow for fiscal 2025 was $283.0M, up 22.0% from $232.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $554.0M. Over the past ten years it has ranged from −$17.0M (fiscal 2023) to $873.0M (fiscal 2021); the current reading is higher than 50% of that period. Bausch + Lomb Corporation ranks 12th of 51 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $283.0M | 21.98% |
| FY2024 | $232.0M | — |
| FY2023 | −$17.0M | — |
| FY2022 | $345.0M | (60.48%) |
| FY2021 | $873.0M | 67.24% |
| FY2020 | $522.0M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $233.0M | 52.29% |
| Jun 2026 | $153.0M | 378.13% |
| Mar 2026 | $32.0M | (76.47%) |
| Dec 2025 | $136.0M | (0.73%) |
| 20 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| COO The Cooper Companies, Inc. compare | $1.0B |
| ALGN Align Technology, Inc. compare | $749.9M |
| AVTR Avantor, Inc. compare | $584.7M |
| ATR AptarGroup, Inc. compare | $573.5M |
| BLCO Bausch + Lomb Corporation | $554.0M |
| MMSI Merit Medical Systems, Inc. compare | $273.7M |
| RGEN Repligen Corporation compare | $129.9M |
| TFX Teleflex Incorporated compare | $129.3M |
| MMED MiniMed Group, Inc. compare | −$134.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on BLCO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement